NorthCrest Asset Manangement’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
RG
ECSS
LT
NorthCrest Asset Manangement's TMO Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its Thermo Fisher Scientific (TMO) stake by 5% in Q2 2026, buying an estimated $928K and bringing the position to 40,344 shares worth $21.2M. The position accounts for 0.54% of the portfolio, ranked #42.
NorthCrest Asset Manangement first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $36.4M in Q4 2021. 1,102 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- NorthCrest Asset Manangement held 40,344 shares of Thermo Fisher Scientific worth $21.2M as of Q2 2026.
- NorthCrest Asset Manangement bought 1,933 Thermo Fisher Scientific shares in Q2 2026, an estimated $928K.
- Thermo Fisher Scientific made up 0.54% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #42 holding.
- NorthCrest Asset Manangement first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's Thermo Fisher Scientific position peaked at $36.4M in Q4 2021.
- 1,102 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.